Likelihood ratios to apply for nasal bone, ductus venosus and tricuspid flow at the 11-13 weeks' scan in down syndrome screening

Fetal Diagnosis and Therapy

Volumn 34, Issue 2, 2013, Pages 116-120

  Illa, Miriam ^a   Mula, Raquel ^a   Arigita, Marta ^a   Grande, Maribel ^a   Gonce, Anna ^a   Borobio, Virginia ^a   Borrell, Antoni ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Antenatal screening; Down syndrome; Ductus venous; Fetal nuchal translucency; First trimester; Nasal bone; Noninvasive prenatal diagnosis; Tricuspid flow; Ultrasound markers; Ultrasound screening

Indexed keywords

ADULT; ARTICLE; BLOOD FLOW; BODY MASS; DOWN SYNDROME; DUCTUS VENOSUS; FALSE POSITIVE RESULT; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; INTERMEDIATE RISK POPULATION; MAJOR CLINICAL STUDY; NASAL BONE; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PRIORITY JOURNAL; SCREENING; TRICUSPID FLOW; TRISOMY 21;

ADULT; DOWN SYNDROME; FALSE POSITIVE REACTIONS; FEASIBILITY STUDIES; FEMALE; HUMANS; LIKELIHOOD FUNCTIONS; NASAL BONE; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, FIRST; SENSITIVITY AND SPECIFICITY;

EID: 84883458172     PISSN: 10153837     EISSN: 14219964     Source Type: Journal    
DOI: 10.1159/000351854     Document Type: Article

References (26)

1. Borrell A, Casals E, Fortuny A, Farre MT, Gonce A, Sanchez A, Soler A, Cararach V, Vanrell JA: First-trimester screening for tri-somy 21 combining biochemistry and ultrasound at individually optimal gestational ages. An interventional study. Prenat Diagn 2004; 24:541-545.
2. Kagan KO, Wright D, Baker A, Sahota D, Nicolaides KH: Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-a. Ultrasound Obstet Gynecol 2008; 31: 618-624.
3. Kagan KO, Etchegaray A, Zhou Y, Wright D, Nicolaides KH: Prospective validation of first-trimester combined screening for triso-my 21. Ultrasound Obstet Gynecol 2009; 34: 14-18.
4. Cicero S, Curcio P, Papageorghiou A, Sonek J, Nicolaides K: Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks of gestation: An observational study. Lancet 2001; 358:1665-1667.
5. Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O: Multicenter study of first-trimester screening for trisomy 21 in 75, 821 pregnancies: Results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol 2005; 25:221-226.
6. Borrell A, Gonce A, Martinez JM, Borobio V, Fortuny A, Coll O, Cuckle H: First-trimester screening for down syndrome with ductus ve-nosus Doppler studies in addition to nuchal translucency and serum markers. Prenat Di-agn 2005; 25:901-905.
7. Maiz N, Valencia C, Kagan KO, Wright D, Nicolaides KH: Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and turner syndrome at 11-13 weeks of gestation. Ultrasound Obstet Gynecol 2009; 33:512-517.
8. Kagan KO, Cicero S, Staboulidou I, Wright D, Nicolaides KH: Fetal nasal bone in screening for trisomies 21, 18 and 13 and turner syndrome at 11-13 weeks of gestation. Ultrasound Obstet Gynecol 2009; 33:259-264.
9. Borrell A, Robinson JN, Santolaya-Forgas J: Report on the 11-to 13 + 6-week ultrasound evaluation as a screening test for trisomy 21 in singleton pregnancies. Am J Perinatol 2009; 26:703-710.
10. Kagan KO, Valencia C, Livanos P, Wright D, Nicolaides KH: Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and turner syndrome at 11 + 0 to 13 + 6 weeks of gestation. Ultrasound Obstet Gynecol 2009; 33:18-22.
11. Munoz-Cortes M, Arigita M, Falguera G, Seres A, Guix D, Baldrich E, Acera A, Torrent A, Rodriguez-Veret A, Lopez-Quesada E, Garcia-Moreno R, Gonce A, Borobio V, Bor-rell A: Contingent screening for down syndrome completed in the first trimester: A multicenter study. Ultrasound Obstet Gyne-col 2012; 39:396-400.
12. Ekelund CK, Petersen OB, Sundberg K, Ped-ersen FH, Vogel I, Tabor A: Screening performance for trisomy 21 comparing first trimester combined screening and a first trimester contingent screening protocol including duc-tus venosus and tricuspid flow. Prenat Diagn 2012; 32:783-788.
13. Sainz JA, Serrano R, Borrero C, Turmo E: First trimester contingent test as a screening method for down's syndrome. A prospective study in the general population. J Matern Fetal Neonatal Med 2012; 25:2221-2224.
14. Molina Garcia FS, Carrillo Badillo MP, Zara-goza Garcia EA, Fernandez de Santos AG, Montoya Ventoso F: Analysis of secondary ultrasound markers in the first trimester before chorionic villus sampling. Prenat Diagn 2010; 30:1117-1120.
15. Karadzov-Orlic N, Egic A, Milovanovic Z, Marinkovic M, Damnjanovic-Pazin B, Lukic R, Joksic I, Curkovic A, Mikovic Z: Improved diagnostic accuracy by using secondary ultrasound markers in the first-trimester screening for trisomies 21, 18 and 13 and turner syndrome. Prenat Diagn 2012; 32:638-643.
16. Robinson HP, Fleming JE: A critical evaluation of sonar 'Crown-rump length' Measurements. Br J Obstet Gynaecol 1975; 82:702-710.
17. Borobio V, Borrell A, Penalva V, Puerto B, Cararach V: Nasal bone assessment in first trimester detection of trisomy 21. International world congress-25-29 September 2005, Vancouver, Canada. Ultrasound Obstet Gy-necol 2005; 26:376-471.
18. Borrell A, Martinez JM, Seres A, Borobio V, Cararach V, Fortuny A: Ductus venosus assessment at the time of nuchal translucency measurement in the detection of fetal aneu-ploidy. Prenat Diagn 2003; 23:921-926.
19. Falcon O, Faiola S, Huggon I, Allan L, Nico-laides KH: Fetal tricuspid regurgitation at the 11 + 0 to 13 + 6-week scan: Association with chromosomal defects and reproducibility of the method. Ultrasound Obstet Gynecol 2006; 27: 609-612.
20. Nicolaides KH: Screening for chromosomal defects. Ultrasound Obstet Gynecol 2003; 21: 313-321.
21. Agathokleous M, Chaveeva P, Poon LC, Ko-sinski P, Nicolaides KH: Meta-analysis of second-trimester markers for trisomy 21. Ultrasound Obstet Gynecol 2013; 41:247-261.
22. Cicero S, Longo D, Rembouskos G, Sacchini C, Nicolaides KH: Absent nasal bone at 11-14 weeks of gestation and chromosomal defects. Ultrasound Obstet Gynecol 2003; 22:31-35.
23. Peralta CF, Falcon O, Wegrzyn P, Faro C, Nicolaides KH: Assessment of the gap between the fetal nasal bones at 11 to 13 + 6 weeks of gestation by three-dimensional ultrasound. Ultrasound Obstet Gynecol 2005; 25:464-467.
24. Malone FD, Ball RH, Nyberg DA, Comstock CH, Saade G, Berkowitz RL, Dugoff L, Craigo SD, Carr SR, Wolfe HM, Tripp T, D'Alton ME: First-trimester nasal bone evaluation for aneuploidy in the general population. Obstet Gynecol 2004; 104:1222-1228.
25. Ghaffari SR, Tahmasebpour AR, Jamal A, Hantoushzadeh S, Eslamian L, Marsoosi V, Fattahi F, Rajaei M, Niroomanesh S, Borna S, Beigi A, Khazardoost S, Saleh-Gargari S, Ra-himi-Sharbaf F, Farrokhi B, Bayani N, Teh-rani SE, Shahsavan K, Farzan S, Moossavi S, Ramezanzadeh F, Dastan J, Rafati M: First-trimester screening for chromosomal abnormalities by integrated application of nuchal translucency, nasal bone, tricuspid regurgita-tion and ductus venosus flow combined with maternal serum free beta-hcg and papp-a: A 5-year prospective study. Ultrasound Obstet Gynecol 2012; 39:528-534.
26. Gekas J, Durand A, Bujold E, Vallee M, Forest JC, Rousseau F, Reinharz D: Cost-effectiveness and accuracy of prenatal down syndrome screening strategies: Should the combined test continue to be widely used? Am J Obstet Gynecol 2011; 204:175. e171-e178.